Addressing the Challenges of Cold Agglutinin Disease: From Diagnosis to Treatment

C

Sutimlimab in Cold Agglutinin Disease: Safety From the Phase 3 Cardinal and Cadenza Studies

By Catherine Broome 5 Videos
239 views
April 15, 2024
Comments 0
Login to view comments. Click here to Login
16:07

Current Management of CAD and the Role of Complement Activation

Shirley D'Sa

45 views
13:52

Diagnosis and Testing Considerations for Cold Agglutinin Disease

Julia Cunningham

171 views
23:57

The Role of Complement in Disease: Focus on PNH, aHUS, CAPS, and CAD

Ilene Weitz

151 views
13:41

CAD: The Basics and Development

Kelly Davidson

354 views
18:39

CAD: The Importance of Treatment Continuity

Sigbjørn Berentsen

68 views
20:56

Sutimlimab in Cold Agglutinin Disease

Kelly Davidson

166 views
10:29

2-Year Results From the CARDINAL Study: Sutimlimab for Complement C1…

Catherine Broome

67 views
22:22

Cold Agglutinin Disease: Pharmacologic Treatment and Clinical Monito…

Irina Murakhovskaya

222 views
07:59

CARDINAL Trial 2-Year Follow-Up: Long-Term Sutimlimab for Patients W…

Keck School of Medicine of USC

I. Weitz

158 views
34:15

Advances in Hemolytic Anemias: Enzymopathies, Membrane Defects, Auto…

Scripps Health

I. Weitz

544 views
32:32

Refractory Cold Agglutinin Disease Overview and Case Discussion

BMFcases

S. Berentsen, T. Bat

319 views
12:34

Yale ASH Updates on Classical Hematology: PROs of Sutimlimab Use in …

Yale Cancer Center

G. Goshua

347 views